{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:07:32Z","timestamp":1791310052066,"version":"4.3.1"},"publisher-location":"Chichester, UK","reference-count":28,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001909","type":"reference-entry","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T03:33:39Z","timestamp":1069385619000},"source":"Crossref","is-referenced-by-count":29,"title":["Lamotrigine add-on for drug-resistant partial epilepsy"],"prefix":"10.1002","author":[{"given":"Sridharan","family":"Ramaratnam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony G","family":"Marson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gus A","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,7,23]]},"reference":[{"key":"10.1002\/14651858.CD001909-BIB1|cit1","first-page":"230","article-title":"Neuropsychological assessment in lamotrigine treated epileptic patients","volume":"28","author":"Banks","year":"1991","journal-title":"Clinical and Experimental Neurology"},{"key":"10.1002\/14651858.CD001909-BIB2|cit2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/0920-1211(89)90007-7","article-title":"Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy","volume":"4","author":"Binnie","year":"1989","journal-title":"Epilepsy Research"},{"key":"10.1002\/14651858.CD001909-BIB3|cit3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1600-0404.1996.tb07060.x","article-title":"Controlled trial of lamotrigine (Lamictal) for treatment-resistant partial seizures","volume":"94","author":"Boas","year":"1996","journal-title":"Acta Neurologica Scandinavica"},{"issue":"8","key":"10.1002\/14651858.CD001909-BIB4|cit4","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1212\/WNL.53.8.1724","article-title":"A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children","volume":"53","author":"Duchowny","year":"1999","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD001909-BIB5|cit5","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1528-1157.1989.tb05309.x","article-title":"Controlled trial of lamotrigine (lamictal) for refractory partial seizures","volume":"30","author":"Jawad","year":"1989","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001909-BIB6|cit6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/0920-1211(90)90099-H","article-title":"A randomised double-blind placebo -controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures","volume":"7","author":"Loiseau","year":"1990","journal-title":"Epilepsy Research"},{"key":"10.1002\/14651858.CD001909-BIB7|cit7","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1212\/WNL.43.11.2284","article-title":"Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. US Lamotrigine Protocol 0.5 Clinical Trial Group","volume":"43","author":"Matsuo","year":"1993","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD001909-BIB8|cit8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1528-1157.1994.tb02920.x","article-title":"Lamotrigine therapy for partial seizures: A multicenter, placebo-controlled, double-blind, cross-over trial","volume":"35","author":"Messenheimer","year":"1994","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001909-BIB9|cit9","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1212\/01.wnl.0000277698.33743.8b","article-title":"Lamotrigine extended-release as adjunctive therapy for partial seizures","volume":"69","author":"Naritoku","year":"2007","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001909-BIB10|cit10","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1212\/01.wnl.0000285493.08622.35","article-title":"Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months","volume":"70","author":"Pi\u00f1a-Garza","year":"2008","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001909-BIB11|cit11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0896-6974(95)00034-B","article-title":"Lamotrigine: a six-month, placebo-controlled, safety and tolerance study","volume":"8","author":"Schachter","year":"1995","journal-title":"Journal of Epilepsy"},{"key":"10.1002\/14651858.CD001909-BIB12|cit12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/jnnp.56.5.448","article-title":"Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures","volume":"56","author":"Schapel","year":"1993","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001909-BIB13|cit13","first-page":"66","article-title":"Add-on treatment with lamotrigine for intractable partial epilepsy: a placebo-controlled, cross-over trial","volume":"34 Suppl","author":"Schmidt","year":"1993","journal-title":"Epilepsia"},{"issue":"2","key":"10.1002\/14651858.CD001909-BIB14|cit14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1528-1157.1993.tb02417.x","article-title":"Outcomes of add-on treatment with lamotrigine in partial epilepsy","volume":"34","author":"Smith","year":"1993","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001909-BIB15|cit15","first-page":"135","article-title":"Controlled trial of lamotrigine for the treatment of refractory partial seizures","volume":"45 Suppl 3","author":"Carignani","year":"2004","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001909-BIB16|cit16","first-page":"124","article-title":"Controlled trial of lamotrigine for the treatment of refractory partial seizures","volume":"47 Suppl 3","author":"Carignani","year":"2006","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001909-BIB17|cit17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0920-1211(90)90077-9","article-title":"A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy","volume":"6","author":"Sander","year":"1990","journal-title":"Epilepsy Research"},{"key":"10.1002\/14651858.CD001909-BIB18|cit18","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1136\/jnnp.57.8.921","article-title":"Vigabatrin and lamotrigine in refractory epilepsy","volume":"57","author":"Stolarek","year":"1994","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD001909-BIB19|cit19","first-page":"97","article-title":"Use of lamotrigine as adjunctive therapy in patients with mental retardation and epilepsy. An interim analysis of a double blind study with evaluation of behavioural effects","volume":"41(Suppl Floren","author":"Veendrick-Meekes","year":"2000","journal-title":"Epilepsia"},{"issue":"10","key":"10.1002\/14651858.CD001909-BIB20|cit20","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/j.1528-1157.1998.tb01295.x","article-title":"Neuropsychological outcomes in randomized controlled trials of antiepileptic drugs: a systematic review of methodology and reporting standards","volume":"39","author":"Cochrane","year":"1998","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001909-BIB21|cit21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0140-6736(95)91208-8","article-title":"Remission of epilepsy: results from the national general practice study of epilepsy","volume":"346","author":"Cockerell","year":"1995","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD001909-BIB22|cit22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","year":"1989","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD001909-BIB23|cit23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1528-1157.1993.tb02586.x","article-title":"Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935 -1984","volume":"34","author":"Hauser","year":"1993","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001909-BIB24|cit24","article-title":"Lamotrigine","volume-title":"Mechanisms of action in antiepileptic drugs","author":"Leach","year":"1995"},{"key":"10.1002\/14651858.CD001909-BIB25|cit25","unstructured":"Lefebvre   C Manheimer   E Glanville   J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated September 2009). The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD001909-BIB26|cit26","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/bmj.313.7066.1169","article-title":"New antiepileptic drugs: a systematic review of their efficacy and tolerability","volume":"313","author":"Marson","year":"1996","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD001909-BIB27|cit27","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1528-1157.1997.tb01251.x","article-title":"The new antiepileptic drugs: a systematic review of their efficacy and tolerability","volume":"38(8)","author":"Marson","year":"1997","journal-title":"Epilepsia"},{"issue":"5","key":"10.1002\/14651858.CD001909-BIB28|cit28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/jnnp.61.5.433","article-title":"Epidemiology of the epilepsies","volume":"61","author":"Sander","year":"1996","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001909.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T00:00:00Z","timestamp":1466553600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD001909\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:06:56Z","timestamp":1628543216000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001909"}},"subtitle":[],"editor":[{"given":"Sridharan","family":"Ramaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2001,7,23]]},"references-count":28,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001909","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD001909.pub2","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2001,7,23]]}}}